Sam-A Pharm. Co., Ltd (KOSDAQ:009300)
South Korea · Delayed Price · Currency is KRW 16,140
+10 (0.06%)
At close: Feb 13, 2026
Sam-A Pharm. Market Cap
Sam-A Pharm. has a market cap or net worth of 98.51 billion as of February 13, 2026. Its market cap has decreased by -5.83% in one year.
Market Cap
98.51B
Enterprise Value
16.01B
Revenue
76.66B
Ranking
n/a
PE Ratio
7.47
Stock Price
16,140.00
Market Cap Chart
Since November 29, 2000, Sam-A Pharm.'s market cap has increased from 32.75B to 98.51B, an increase of 200.80%. That is a compound annual growth rate of 4.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 98.51B | 2.74% |
| Dec 30, 2025 | 95.88B | -5.98% |
| Dec 30, 2024 | 101.99B | 1.89% |
| Dec 28, 2023 | 100.09B | -1.50% |
| Dec 29, 2022 | 101.62B | -13.95% |
| Dec 30, 2021 | 118.10B | 16.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HYUNDAI BIOLAND | 132.90B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 113.27B |
| Pharos iBio | 110.17B |
| Ahn-Gook Pharmaceutical | 100.24B |
| H.PIO | 99.27B |
| Daehan Nupharm | 93.62B |
| Hwail Pharmaceutical | 91.03B |
| Sinsin Pharmaceutical | 89.96B |